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Last but certainly not least, I would like to thank my friends and family for their unconditional supports while I worked towards this degree. damage has yet to be understood. Here we discovered interactions between CTD peptides and various Drosha-associated proteins (DAPs) by a mass spectrometry pulldown experiment. By applying a number of in vitro binding assays, we identified that CTD interacts with DiGeorge syndrome critical region 8 (DGCR8), one of the key and necessary proteins in the Microprocessor complex responsible for miRNA biogenesis. We also showed that the CTD-DGCR8 interaction can be enhanced in the presence of active preserve the genome and to ultimately achieve the survival of the damaged cell [2] . An alternative delay response towards persistent DNA damage is to induce senescence or cell death through apoptosis [2] . The delay response aims to reduce the harmful effects, and to protect the organism by minimizing potential damage.
Exposure to Genotoxin, such as some anti-cancer agents used in cancer therapy, can cause DNA modification and create critical DNA lesions. These DNA lesions can obstruct normal functions of the DNA, such as transcription and DNA replication [3] .
Previous studies have shown that DNA lesions can trigger apoptosis as a self-protecting mechanism [2, 3] .
Abl Kinase
In this lab we have discovered that nuclear Abl tyrosine kinase can be activated by genotoxins, such as cisplatin, to induce apoptosis [3] . Abl has been previously identified as a proto-oncogene that contains oncogenic potential [4] . On the contrary, studies from this lab have also shown that Abl induces apoptosis via a p53 and its related p73 transcription factor dependent pathway, and therefore it acts as a pro-apoptotic, or antioncogenic factor [5] . In addition to the p53 and p73 dependent apoptotic pathway, Abl has also been shown to induce tyrosine phosphorylation on RNA polymerase II (RNAPII) at its Carboxyl-terminal domain (CTD) [6] [7] [8] . By utilizing its SH2 kinase domain and the CTD-interacting domain (CID), Abl is capable of phosphorylating RNAPII at its CTD on the tyrosine residues, which located on the first position of the CTD heptad repeats.
Moreover, mutant Abl lacking CID is able to auto-phosphorylate itself, but unable to phosphorylate on the CTD [6] [7] [8] .
C-Terminal Repeated Domain (CTD)
CTD is consisted of heptad amino acid residues with the consensus sequence repeat of Tyr-Ser-Pro-Thr-Ser-Pro-Ser for 26 times in the yeast RNA Pol II and for 52 times in the mammalian RNA Pol II. Among the seven amino acid residues, Tyr-1, Pro-3, Ser-5, and Pro-6 are conserved among all repeats [9] . While CTD is not required for mRNA synthesis, it is critical for cell survival, because it interacts with essential proteins which process mRNA during transcription [10] . CTD is served as a platform to recruit various enzymes and factors that are responsible for the transcriptional processing of nascent RNA, including capping, splicing, and polyadenylation of RNA transcripts [11] .
The CTD platform can thus easily change shape and orientation based upon its phosphorylated conditions on Tyr-1, Ser-2, and Ser-5 positions mediated by different protein kinases, including the previously mentioned Abl kinase on Tyr-1 [12] . In general, RNA polymerase II with an unphosphorylated CTD is found in the transcription initiating complex at the promoters; whereas the CTD-phosphorylated RNA polymerase II is found in the transcription elongation complex located at the actively transcribing region of a gene [13] . To begin transcription, the protein kinase in TFIIH phosphorylates CTD at its Ser-5 position to stimulate transcription elongation and RNA 5'capping. Then, as CTD gets phosphorylated at the Ser-2 position, the stimulation of RNA splicing and polyadenylation are both in motion. Finally, CTD is de-phosphorylated and recycled back to the promoter after the dissociation of nascent RNA [13] . As mentioned earlier, tyrosine phosphorylation of CTD by the active Abl kinase can be induced during DNA damage.
However, the exact purpose and mechanism behind the role of tyrosine phosphorylation of CTD and its regulation are still largely unknown.
Biogenesis of miRNA
MicroRNAs (miRNAs) are small single-stranded RNAs that inhibit translation by inducing degradation of messenger RNAs (mRNAs) via mostly the binding to mRNA's 3' -untranslated region (3'UTR) [14] . The biogenesis of miRNA begins by RNA transcription catalyzed by RNA Polymerase II. The crude transcript, known as primary-miRNA ( pri-miRNA), is generally a few kilo-bases in length, and contains unique stemloop structures that can be recognized and bound by active miRNA Microprocessor complex [15] . Once bound, Drosha, a type III RNase, acts as the effector of Microprocessor complex, and cleaves the pri-miRNA strand, thereby releasing a small hairpin shaped RNA known as the pre-miRNA [16] . From here the pre-miRNA is transported out to cytoplasm via the interaction with exportin-5. Once it arrives in cytoplasm, the pre-miRNA can be further processed by Dicer, which is also a RNase, to generate a ~22 nucleotides long RNA duplex [14] . Finally, one of the two 22 nucleotides strands is loaded onto the RNA induced silencing complex (RISC) as the mature effector miRNA, while the other strand gets degraded [17] .
miRNA Microprocessor Complexes
It has been shown that the Microprocessor complex exists in two forms. The larger Microprocessor complex is composed of multiple classes of RNA-associated proteins, including various of RNA binding proteins, heterogenous nuclear ribonucleoproteins, and Ewing sarcoma family proteins. Although the larger Microprocessor complex is consisted of Drosha, yet it appears to be catalytically inactive. [15] . On the other hand, the active Microprocessor complex is consisted of only Drosha and its critical co-factor protein named DiGeorge Critical Region 8 (DGCR8).
DGCR8, also known as Pasha in other literatures, was first identified as a Droshainteracting protein through immunoprecipitation (IP) from human cells. Experiments have shown that when DGCR8 is absent from miRNA processing, pri-miRNA level accumulates, whereas pre-miRNA and mature miRNA levels decline [18] . Such results suggest that DGCR8 plays an essential role in the processing of pri-miRNA, regardless of its inability to directly cleave RNAs. The human DGCR8 is a ~85 kilo-Dalton protein containing 773 amino acids. It consists of two double-stranded RNA Binding Domain (dsRBD), as well as a small region at the C-terminus end that interacts directly with Drosha. Experiments done by employing various DGCR8 mutant constructs have shown that the region of its first 275 amino acid residues is responsible for nuclear localization.
In addition, DGCR8 also contains of a WW domain near the center region [19] . Unlike the other identified domains within DGCR8, the role which the WW domain acts on DGCR8 is much less understood. A recent publication has reported that the WW domain of DGCR8 can act as a platform for extensive dimerization interaction among two DGCR8 proteins [20] .
Discovery of interactions between Drosha-associated proteins (DAP) and pY1pS5-

CTD peptides
To investigate the roles played by different phosphorylated states of CTD in RNA transcription, Dr. Gabriel Pineda, a former post-doctoral investigator from our lab, collaborated with a proteomics lab at UCSD in 2008. He conducted a pull-down experiment to identify CTD-associated proteins using MUDPIT mass spectrometry system. By applying biotinylated-phospho-CTD peptides of different phosphorylated states to the nuclear extracts of HeLa cells, a number of proteins were shown to display differential bindings to differentially phosphorylated CTD-peptides (table. 1 ). An especially intriguing result from this mass spectrometry assay reveals that the pY1pS5phosphorylated CTD peptide specifically pulled-down a group of 13 proteins that have been previously found to associate with Drosha as part of the miRNA Microprocessor complex [15] .
The result from Dr. Pineda's mass spectrometry pull-down experiment prompted further investigations in order to confirm and to understand more on how the CTD peptides interact with the miRNA Microprocessor complex. In other words, which of the Drosha-associated proteins (DAP) are responsible for the direct interaction with the CTD peptides under different phosphorylated conditions.
Interaction between CTD and Ewing sarcoma family proteins (EWS) with or without the presence of Abl Kinase is not clearly observed
We began this project by isolating the most likely candidates among DAPs, and to investigate their involvement in the interaction with differentially phosphorylated states of CTD peptides. The first DAP chosen and acquired for this investigation was the Ewing sarcoma family protein (EWS). EWS was among the DAPs pulled-down by pY1pS5phosphorylated CTD peptide in Dr. Pineda's mass spectrometry experiment, and it is known to be part of the larger miRNA Microprocessor complex [15] .
To confirm the interaction between CTD and EWS, a CTD tagged with pGLUE tag, which consists of a Strept-tag, a HA-tag, a TEV recombinant site, and a calmodulin binding site (pGLUE-CTD) [21] , as well as an EWS fused with the GST-tag (gst-EWS)
were amplified and prepared. In addition, an active Abl kinase (Abl-PP-NES) was also constructed to apply for the induction of tyrosine phosphorylation in selected samples in order to differentiate levels of interaction among the unphosphorylated-and the Tyr-1 phosphorylated CTD with EWS. We then carried out an immunoprecipitation (IP) assay 
Immunoprecipitation binding assay shows interaction between the CTD and
DGCR8s; such binding is also positively influenced by active Abl kinase
Previous in vitro experiments have shown that the active Microprocessor complex
interacts with pri-miRNAs through the dsRBDs of DGCR8. Moreover, DGCR8 binds to pri-miRNA hairpins before Drosha [18, 22] . Based on these observations, it is logical to suggest a connection between DGCR8 and CTD, which is responsible for RNA transcriptional processing as part of RNA Pol II. To test this hypothesis, we carried out an pulled-down by unphospho-CTD peptides saturated at 1 µg titration; whereas in the pY1pS5-CTD peptides, DGCR8 pulldown saturated at 1ng titration. This result preliminarily suggested that the pY1pS5-CTD-DGCR8 binding has a higher affinity than the unphospho-CTD-DGCR8 binding. In addition, both samples showed no bands in the 10 µg titration, suggesting that such peptide concentration could be over-saturated.
In order to acquire a more complete picture of the interactions between DGCR8 and the CTD peptides, all six available peptides, including: unphospho-CTD, pY1-CTD, pY1pS5-CTD, pS2-CTD, pS5-CTD, and pY1pS2-CTD, were employed to carry out the same binding assay with Flag-DGCR8 in 1 ng, 10 ng, 100 ng, and 1 µg titrations.
DGCR8 pulldown was observed in samples with unphospho-CTD, pY1-CTD, and pY1pS5-CTD in an intensifying fashion in accordance to the increase of peptide concentration ( figure 3b ). On the contrary, samples with pS2-CTD, pS5-CTD, and pY1-pS2-CTD showed no clear increase among different titrations, and the band intensities dispersed at a random fashion (data not shown). After plotting each results on a scatter chart, Unphospho-CTD pulldown of DGCR8 appeared to be a 2nd-order reaction curve;
whereas pY1-CTD and pY1pS5-CTD pulldown of DGCR8 appeared to be linear curve (figure 3c).
Immunoprecipitation assay of Flag-tagged DGCR8 and YAP (both WW domain containing proteins) shows positive CTD pulldowns, which can be detected by CTD antibodies targeting different CTD biochemical properties
The in vitro binding assay of differentially phosphorylated CTD-peptides demonstrated promising results showing the interactions between DGCR8 and unphospho-CTD, pY1-CTD, and pY1pS5-CTD peptides. However, to repeat this result was proven to be more difficult than originally expected due to the unstable nature of these synthetic peptides. Therefore an alternative assay was needed to further confirm the interactions between DGCR8 and differentially phosphorylated conditions of CTD. We decided to resort back to the immunoprecipitation binding assay of Flag-tagged proteins.
In order to differentiate the phosphorylated conditions of each CTD pulled-down by different proteins, multiple CTD-specific antibodies, which target different Yes HeLa nuclear extracts were reacted with each of the four different CTD peptides of four heptad repeats (28 aa), either unphosphorylated (CTD), phosphorylated at the four tyrosines (pY1-CTD), the four serine-5's (pS5-CTD) and doubly phosphorylated (pY1pS5-CTD). The functions of Ser-5 and Ser-2 phosphorylation on the CTD during RNA transcription have been well established by many literatures. In contrast, the roles played by Tyr-1 phosphorylation on the CTD is still largely unknown. While it had been shown that Abl kinase can be activated during DNA damage to induce Tyr-1 phosphorylation on CTD, and ultimately triggers apoptosis in a p53-dependent pathway, the underlying mechanism on how these pathways are interconnected remains relatively uncertain [6] [7] [8] .
Using a mass spectrometry assay, this lab had demonstrated a possible link between the pY1pS5-CTD and many proteins of the miRNA Microprocessor complex. In this project, we have identified DGCR8, a key player in the miRNA biogenesis, as a viable candidate for the interaction between CTD and the Microprocessor complex. Moreover, we have investigated the role Tyr-1 phosphorylation of CTD plays in the CTD-Microprocessor complex interaction.
Before the beginning of this project, the mass spectrometry experiment conducted by Dr. Pineda prompted many intriguing questions on the possible connection between pY1pS5-CTD and the Microprocessor complex. This project began as an attempt to study the mass spectrometry result more specifically. A mass spectrometry generally pulls down more than the proteins involved in direct interaction. Therefore we had to assume that many of the proteins pulled-down in this particular assay were results of indirect interactions. Our first goal was to identify the direct protein interaction between CTD and the Microprocessor complex. On top of that, we were to confirm the validity of the mass spectrometry results using more specific methods.
By conducting immunoprecipitation assays in a system of over-expressed proteins, we now have established that CTD does not directly interact with EWS, a protein that is part of the inactive form of Microprocessor complex, with or without the presence of active Abl kinase (figure 1c). In this project, we over-expressed active Abl kinase in the experimental system to phosphorylate CTD on its Tyr-1 position. However, it is also important to note that the active Abl kinase can phosphorylate tyrosine residues on other proteins as well. Since the activation of Abl kinase results in apoptotic pathway during DNA damage, one of our hypotheses was that miRNA biogenesis is induced as a precursor to the apoptotic pathway. Although EWS is only one of the many proteins belongs to the inactive form of Microprocessor complex, the negative result had us begin forming our hypothesis instead on the idea that an induction of miRNA biogenesis occurs in the event of Abl activation. With this hypothesis in mind, a protein involved in the active form of Microprocessor would be a more likely candidate to interact with the CTD during DNA damage and upon Abl activation. Thus we shifted our focus to DGCR8, a critical co-factor of Drosha that is known to involve in the interaction with RNA transcript during miRNA biogenesis [18] .
In our first pulldown experiment involving DGCR8, Flag-tagged DGCR8 was pulled down by Flag-gel to find out whether the CTD peptides were pulled-down by DGCR8. In this experiment, CTD was pulled-down by DGCR8 in the absence of Abl kinase. Moreover, when active Abl kinase was present, such pulldown increased, suggesting that Abl kinase played a role in stabilizing the DGCR8-CTD interaction. In order to see whether Abl stabilized such interaction via its tyrosine phosphorylation activity, Gleevec, a drug that inhibits Abl's kinase activity, was added to one of the samples. When Gleevec was added, the CTD pulldown decreased slightly, suggesting that the tyrosine phosphorylation by Abl had contributed to the CTD-DGCR8 interaction ( figure 2b ). An alternative pulldown experiment was conducted by pulling down the CTD peptides to find DGCR8. The results from this experiment also confirmed the DGCR8-CTD interaction (figure 2c). What these results did not provide was a definitive answer on whether the increase of DGCR8-CTD interaction was caused by the phosphorylation on the Tyr-1 position of the CTD.
The initial mass spectrometry assay was conducted by using specifically designed CTD peptides, which consisted of four YSPTSPS amino acid repeats. Since these peptides were biochemically made to be differentially phosphorylated on specific amino acid residues, they helped in revealing the specific phosphorylated condition of the CTD peptide involved in the binding. Using these synthetic peptides, DGCR8 was again confirmed to be interacting with unphospho-CTD, pY1-CTD, and pY1pS5-CTD (figure 3b and 3c). However, to repeat this result, or to simply have a positive pulldown proved to be difficult. Numerous attempts were done after the initial pulldown assay, but none succeeded. After thoroughly analyzing each trial, the most probable cause for the failures was the fact that these peptides are too volatile. Moreover, these 4-heptad repeat peptides were much smaller in size compared to the endogenous 52-heptad repeat CTD. It is not hard to imagine that landing an aircraft onto a massive runway would be much easier than to land the same aircraft onto an aircraft carrier. Same logic applies, since the CTD acts as a platform for proteins to bind to, the synthetic peptide, consisted of only 4-heptad repeats, is a much more difficult platform for interaction, especially when compared to the endogenous form of CTD, which is consisted of 52-heptad repeats.
Since the in vitro binding assay based on synthetic CTD peptides was not working as well as we hoped, an alternative assay was required to confirm the DGCR8-CTD interaction. In order to explore the phosphorylated conditions of which the CTD can be pulled-down by DGCR8, we decided to utilize all the appropriate CTD-specific antibodies in our lab, including: Ser-5-, Ser-2-, phospho-, and unphospho-CTD-specific antibodies. Additionally, we also took a closer look at the protein motifs identified on DGCR8. The WW domain near the center of this protein is one of the least understood sites on DGCR8 in terms of its function. Together with a literature search that showed the WW domain on Yes-associated protein (YAP) is responsible for its interaction with CTD [25] , we became interested in finding out if DGCR8 also interacts with CTD via its WW domain. To test the similarities between the two WW domains, and to confirm YAP WW domain's interaction with CTD, we included YAP in our CTD antibody assay.
As shown in figure 4, this experiment suggested that, interestingly, all three proteins, including: CID, YAP, and DGCR8 were pulled-down by CTD, but could be detected only by specific CTD antibodies. The CTD pulled-down by CID was detected by Ser-2 and Ser-5 specific antibodies; the CTD pulled-down by YAP was detected by unphospho-CTD specific antibody; and the CTD pulled-down by DGCR8 was detected by phospho-CTD specific antibody. This result successfully confirmed that YAP interacts with the unphosphorylated CTD, and that it interacts with neither the serine phosphorylated nor the tyrosine phosphorylated CTD. On the other hand, DGCR8 interacts with the phosphorylated CTD, but was detected by neither of the serine phosphorylated CTD antibodies. The result suggests that, while all three of these proteins are CTD-interacting proteins, the specific sites and phosphorylated conditions responsible for the CTD bindings are all different.
Based on the findings of this project, we can so far conclude that the interaction between CTD and the Microprocessor complex can be mediated by DGCR8.
Furthermore, such interaction is enhanced by tyrosine phosphorylation on the first positions of each heptad CTD repeats. The results support the idea that, during RNA transcription, once DNA damage is detected, Abl kinase can be activated to induce Tyr-1 phosphorylation on CTD, and to enhance interaction with the active Microprocessor complex, which then leads to miRNA biogenesis. The finding of this project provided us an alternative perspective to look at the association between the RNA transcription machinery and miRNA Microprocessor complex. While the subject certainly requires more investigations, this project had hopefully shed some light on the less understood role of which the Tyr-1 phosphorylated CTD plays during RNA transcription.
So far the exact protein motif responsible for DGCR8 binding with CTD has not been confirmed. In future experiments, we can utilize the DGCR8 mutant constructs acquired from Dr. Narry Kim's lab to confirm whether the WW domain on DGCR8 interacts with CTD. We have acquired five DGCR8 mutant constructs from Dr. Kim's lab, including: wild-type DGCR8 (1-773), WW domain and dsRBD1/2 containing DGCR8 (276-773), dsRBD1/2 containing DGCR8 (484-773), dsRBD1/2 containing and Drosha interacting site truncated DGCR8 (484-738), and a dsRBD1/2 truncated and WW domain containing DGCR8 (1-483). By employing these DGCR8 mutant constructs on previously described pulldown assays, we can hopefully gain more insights in the binding between DGCR8 and the Tyr-1 phosphorylated CTD.
IV:
Materials and Methods
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Cell culture and transfection. 293T cells were maintained in DMEM medium supplemented with puromycin and 10% FBS. Cells were cultured overnight at 37 degree C to a confluency of 80-85%, and then transiently transfected with expression plasmid (10 µg), using GeneTran reagent following the manufacturer's instructions.
Protein extraction and Western blotting. Protein extracts were harvested and sonicated twice in cold lysis buffer (20 mM Tris [pH 8.0], 100 mM NaCl, 1 mM EDTA, 1% NP-40, 10% Glycerol, 1 mM dithiothreitol [DTT], and 1 mM PMSF). After centrifugation at 14,000 r.p.m at 4 degree C for 15 minutes, the supernatant was isolated and labeled as whole-cell-lysate (WCL). Protein lysates were separated on 4%-12% Tris-Glycine gels (Invitrogen) or 8% SDS-poly-acrylamide gels, and transferred to Nitrocellulose membrane. Membranes were blocked by 5% milk or 5% BSA (milk blocking for mouse antibodies and BSA blocking for rabbit antibodies) for 30 minutes before antibodies were added before they were incubated for three hours to overnight.
In vitro protein binding assay by antibody-conjugated beads. Antibody-conjugated beads were prepared by incubating the desired pulldown antibody with protein A/G beads (Thermo Scientific) for 3 hours. For Flag-tagged proteins, the conjugated beads were replaced, and applied directly by FLAG Affinity Gels (Sigma). Antibody-conjugated beads were then aliquoted to the mixture of extracted proteins and CHAPS IP buffer (0.1% CHAPS, 50 mM HEPES, 150 mM KCl, 10% Glycerol, 1 mM PMSF, 10 mM NaOV, 50 mM NaF, 10 mM beta-Glycerolphosphate, and10 mM 4NaPP). The mixtures were then rotated in 4 degree C for 5-8 hours before the beads were washed 3 times with 5% TBST, and eluted with SDS sample buffer. Resulting fractions were left in room temperature for 10 minutes before they were boiled for another five minutes. Finally, the fractions were loaded to prepared gels for Western blotting analysis.
In vitro protein binding assay by differentially phosphorylated synthetic CTD peptides. extracted proteins were added to titrated synthetic Streptavidin-tagged CTD peptides and rotated in 4 degree C for 1 hour. Then the mixture was added to Streptavidin agarose beads (Thermo Scientific) prepared in CHAPS IP buffer (0.1% CHAPS, 50 mM HEPES, 150 mM KCl, 10% Glycerol, 1 mM PMSF, 10 mM NaOV, 50 mM NaF, 10 mM beta-Glycerolphosphate, and10 mM 4NaPP). The mixture were then rotated in 4 degree C for another hour before the beads were washed 3 times with 5% TBST, and eluted with SDS sample buffer. Resulting fractions were left in room temperature for 10 minutes before they were boiled for another five minutes. Finally, the fractions were loaded to prepared gels for Western blotting analysis
